A carregar...
Improved outcomes on subcutaneous IgG in patients with humoral immunodeficiency and co-morbid bowel disease
Immunoglobulin replacement can be life-saving for certain individuals with immunodeficiencies. Subcutaneous IgG (SCIG) is an increasingly used method of replacement over intravenous IgG (IVIG), with potential advantages including fewer systemic side effects, no need for IV access, patient-reported i...
Na minha lista:
| Publicado no: | Clin Case Rep Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4813804/ https://ncbi.nlm.nih.gov/pubmed/27042340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15761/CCRR.1000149 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|